NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Piramal Enterprises Limited (NSE: PEL)
PEL Technical Analysis
3
As on 28th Mar 2024 PEL SHARE Price closed @ 849.35 and we RECOMMEND Sell for LONG-TERM with Stoploss of 921.54 & Sell for SHORT-TERM with Stoploss of 889.40 we also expect STOCK to react on Following IMPORTANT LEVELS. |
PELSHARE Price
Open | 869.90 | Change | Price | % |
High | 889.95 | 1 Day | 9.15 | 1.09 |
Low | 847.05 | 1 Week | 7.75 | 0.92 |
Close | 849.35 | 1 Month | -49.15 | -5.47 |
Volume | 5261416 | 1 Year | 214.70 | 33.83 |
52 Week High 2354.25 | 52 Week Low 634.65 |
PEL CURRENT MONTH FUTURE | |||
Close | 849.50 | ||
Contracts Traded | 5269500 | ||
Open Intrest | 336750 | ||
Change In O.I | -87.66 % | ||
Lot Size | 750 |
PEL CURRENT MONTH OPTION | |
Most Active Call | 870.00 |
Most Active put | 850.00 |
Highest O.I Buildup Call | 1000.00 |
Highest O.I Buildup Put | 800.00 |
Expiry Date | 2024-03-28 |
PEL ALL MONTHS OPTIONS | |||
For All PEL Options Click Here |
NSE INDIA Most Active Stocks
IDEA | 13.25 | -0.38% |
IDFCFIRSTB | 75.40 | -3.08% |
YESBANK | 23.20 | 0.22% |
GTLINFRA | 1.60 | 0.00% |
NHPC | 89.70 | 0.96% |
TATASTEEL | 155.85 | 2.06% |
BCG | 13.80 | -1.08% |
MAHABANK | 62.35 | 5.41% |
IRFC | 142.35 | -0.35% |
SOUTHBANK | 27.25 | -1.80% |
NSE INDIA Top Gainers Stocks
GOCLCORP | 454.60 | 19.99% |
NRL | 90.70 | 15.32% |
AEGISCHEM | 446.65 | 13.18% |
VIPIND | 525.50 | 12.89% |
REPRO | 834.35 | 12.02% |
GENESYS | 591.45 | 10.91% |
ONELIFECAP | 30.25 | 10.00% |
IFBIND | 1505.95 | 9.98% |
WEIZMANIND | 110.85 | 9.97% |
OMAXE | 90.55 | 9.96% |
NSE INDIA Top Losers Stocks
PERSISTENT | 3984.55 | -50.81% |
SITINET | 0.55 | -8.33% |
RACE | 325.10 | -6.35% |
RACE | 325.10 | -6.35% |
FCONSUMER | 0.75 | -6.25% |
KHANDSE | 29.35 | -6.23% |
CAMLINFINE | 89.25 | -6.10% |
ORIENTBELL | 347.15 | -6.06% |
KOHINOOR | 38.75 | -5.95% |
DWARKESH | 69.50 | -5.89% |
PEL Daily Charts |
PEL Intraday Charts |
Whats New @ Bazaartrend |
PEL Free Analysis |
|
PEL Important Levels Intraday
RESISTANCE | 932.02 |
RESISTANCE | 905.51 |
RESISTANCE | 889.12 |
RESISTANCE | 872.73 |
SUPPORT | 825.97 |
SUPPORT | 809.58 |
SUPPORT | 793.19 |
SUPPORT | 766.68 |
PEL Target March 2024
4th UP Target | 1156.05 |
3rd UP Target | 1072.25 |
2nd UP Target | 1020.45 |
1st UP Target | 968.65 |
1st DOWN Target | 820.85 |
2nd DOWN Target | 769.05 |
3rd DOWN Target | 717.25 |
4th DOWN Target | 633.45 |
PEL Weekly Target
4th UP Target | 982.32 |
3rd UP Target | 943.57 |
2nd UP Target | 919.62 |
1st UP Target | 895.67 |
1st DOWN Target | 827.33 |
2nd DOWN Target | 803.38 |
3rd DOWN Target | 779.43 |
4th DOWN Target | 740.68 |
PEL Target2024
4th UP Target | 1913.21 |
3rd UP Target | 1598.34 |
2nd UP Target | 1403.71 |
1st UP Target | 1209.08 |
1st DOWN Target | 653.72 |
2nd DOWN Target | 459.09 |
3rd DOWN Target | 264.46 |
4th DOWN Target | -50.41 |
Piramal Enterprises Limited ( NSE INDIA Symbol : PEL )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
PEL Synopsis Technicals View
50 Day EMA |
Close is Below EMA 50 (Short Term) |
Bearish | |
100 Day EMA | Close is Below EMA 100 (Mid Term) | Bearish | |
200 Day EMA | Close is Below EMA 200 (Long Term) | Bearish | |
MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
RSI (14) | RSI is Below 30 | Over Sold | |
MFI (14) | MFI is 28.60 | Sideways | |
CCI (20) | CCI is Below -100 | Over Sold | |
WILLIAM %R (14) | William %R is Below -80 | Over Sold | |
ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
PSAR | Stoploss For Short Sell | 1203.28 | |
10 Day Avg Volume | Traded 1.03 % More then 10 Day Average Volume |
PEL Other Details
Segment | EQ | |
Market Capital | 642499936256.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-Specialty & Generic | |
Offical website | > echo $website ; ?> |
PEL Address
PEL Latest News
PEL Business Profile
Piramal Enterprises Limited operates in financial services and pharmaceuticals businesses in India, North America, Europe, Japan, and internationally. It operates through Pharmaceuticals Manufacturing and Services, and Financial Services segments. The company provides financing to real estate developers, as well as corporate clients in non-real estate sectors. It also offers housing loans to individual customers; builds a retail lending platform; and engages in the investment activities. In addition, the company offers contract development and manufacturing solutions across the drug life cycle, including drug discovery, production, and manufacturing of active pharmaceutical ingredients and formulations; and inhalation and injectable anaesthesia, injectable pain, antibiotics, and other medications, as well as intrathecal spasticity management drugs. Further, it provides over-the-counter products for analgesics, skin care, vitamins and supplements, kids' wellness, digestives, women's health, and hygiene and protection primarily under the Saridon, Lacto Calamine, I-Pill, Supradyn, Polycrol, and Tetmosol brands. The company was formerly known as Piramal Healthcare Limited and changed its name to Piramal Enterprises Limited in July 2012. Piramal Enterprises Limited was incorporated in 1947 and is based in Mumbai, India. Address: Piramal Ananta, Mumbai, India, 400070
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service